Discover 2,411 paid clinical trials in Rockville, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,411
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Location: Washington D.C. DC, Baltimore MD, Richmond VA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06465810
Recruiting
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
for
Venous Thromboembolism (VTE)
Location: Baltimore MD, Westwood NJ, Durham NC, Boston MA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07015905
Phase3, Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Washington D.C. DC, Falls Church VA, Baltimore MD,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase3, Recruiting
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
for
Heart Failure
Location: Baltimore MD, Toronto, Sarnia, Lima OH, Richmond IN,
Sponsor: Pfizer
Sex: All
Age: 18 - 70+
Code: NCT06991257
Phase2, Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Washington D.C. DC, Baltimore MD, Gettysburg PA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06532279
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Location: Washington D.C. DC, Falls Church VA, Baltimore MD,
Sponsor: Eidos Therapeutics, a BridgeBio company
Sex: All
Age: 18 - 70+
Code: NCT06563895
Phase3, Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
for
Cardiovascular Disease
Location: Beltsville MD, Fairfax VA, Falls Church VA, Columbia MD,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07000357
Phase3, Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
for
Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1,
Location: Chevy Chase MD, Hershey PA, New York NY, Detroit MI,
Sponsor: ADARx Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06960213
Phase3, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
for
Colorectal Cancer
Location: Fairfax VA, Baltimore MD, Philadelphia PA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07023289
Phase2, Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
for
Asthma
Location: Silver Spring MD, Ellicott City MD, White Marsh MD,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 17
Code: NCT06307665
Phase3, Recruiting
Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell
for
Renal Cell Carcinoma (Kidney Cancer)
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 18+
Code: NCT07062549
Phase1, Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Silver Spring MD, Fairfax VA, Charlottesville VA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase3, Recruiting
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer,
Location: Washington D.C. DC, Baltimore MD, Newark DE,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07154290
Phase2, Recruiting
Clinical Trial of Approaches to Prostate Cancer Surgery
for
Prostate Cancer
Location: Washington D.C. DC, Baltimore MD, New York NY,
Sponsor: Weill Medical College of Cornell University
Sex: Male
Age: 40 - 70+
Code: NCT05155501
Recruiting
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
for
Colon Cancer, Rectal Cancer, Colorectal Cancer,
Location: Columbia MD, Wynnewood PA, Norfolk VA, Salem VA,
Sponsor: SCRI Development Innovations, LLC
Sex: All
Age: 18+
Code: NCT07011576
Phase2, Recruiting
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
for
Malignant Glioma
Location: Washington D.C. DC, Baltimore MD, Wilmington DE,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 21
Code: NCT05099003
Phase1, Phase2, Recruiting
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
for
Advanced Solid Tumor, Non Small Cell Lung Cancer,
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Synthekine
Sex: All
Age: 18+
Code: NCT05098132
Phase1, Phase2, Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)